Page last updated: 2024-11-03

prazosin and Pelvic Pain

prazosin has been researched along with Pelvic Pain in 10 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Pelvic Pain: Pain in the pelvic region of genital and non-genital origin.

Research Excerpts

ExcerptRelevanceReference
"To explore the efficacy of levofloxacin, terazosin, and their combination in patients with category III chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)."9.22A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome. ( Liang, K; Wang, J; Xu, Z; Yan, D, 2016)
"To investigate the efficacy and safety of the alpha1-receptor inhibitor terazosin combined with chlormezanone in the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)."9.14[Retrospective analysis of the combined therapy of terazosin with chlormezanone for chronic prostatitis/chronic pelvic pain syndrome]. ( Li, HJ; Li, HZ; Yan, S; Zhang, XY, 2009)
"To evaluate the clinical efficacy and safety of dexketoprofen trometamol in the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)."9.14[Dexketoprofen trometamol in the treatment of chronic prostatitis/chronic pelvic pain syndrome]. ( Jiang, MH; Liu, HL; Wu, GC, 2009)
"To evaluate the initial, long-term, and durable response rates to terazosin, placebo, or other therapies in patients with chronic prostatitis/chronic pelvic pain syndrome."9.11Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. ( Cheah, PY; Khor, T; Krieger, JN; Liong, ML; Teh, CL; Yang, JR; Yap, HW; Yuen, KH, 2004)
"We evaluate terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome."9.10Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. ( Cheah, PY; Khor, T; Krieger, JN; Liong, ML; Teh, CL; Yang, JR; Yap, HW; Yuen, KH, 2003)
"To explore the efficacy of levofloxacin, terazosin, and their combination in patients with category III chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)."5.22A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome. ( Liang, K; Wang, J; Xu, Z; Yan, D, 2016)
"To investigate the efficacy and safety of the alpha1-receptor inhibitor terazosin combined with chlormezanone in the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)."5.14[Retrospective analysis of the combined therapy of terazosin with chlormezanone for chronic prostatitis/chronic pelvic pain syndrome]. ( Li, HJ; Li, HZ; Yan, S; Zhang, XY, 2009)
"To evaluate the clinical efficacy and safety of dexketoprofen trometamol in the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)."5.14[Dexketoprofen trometamol in the treatment of chronic prostatitis/chronic pelvic pain syndrome]. ( Jiang, MH; Liu, HL; Wu, GC, 2009)
"To evaluate the initial, long-term, and durable response rates to terazosin, placebo, or other therapies in patients with chronic prostatitis/chronic pelvic pain syndrome."5.11Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. ( Cheah, PY; Khor, T; Krieger, JN; Liong, ML; Teh, CL; Yang, JR; Yap, HW; Yuen, KH, 2004)
"We evaluate terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome."5.10Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. ( Cheah, PY; Khor, T; Krieger, JN; Liong, ML; Teh, CL; Yang, JR; Yap, HW; Yuen, KH, 2003)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's6 (60.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, XY2
Luo, SB1
Zhang, JY1
Meng, ZC1
Wang, J1
Yan, D1
Liang, K1
Xu, Z1
Papeš, D1
Pasini, M1
Jerončić, A1
Yan, S1
Li, HZ1
Li, HJ1
Jiang, MH1
Wu, GC1
Liu, HL1
Cheah, PY2
Liong, ML2
Yuen, KH2
Teh, CL2
Khor, T2
Yang, JR2
Yap, HW2
Krieger, JN2
Minervini, A1
Lapini, A1
Serni, S1
Carini, M1
Paick, JS1
Lee, SC1
Ku, JH1
Drabick, JJ1
Gambel, JM1
Mackey, JF1

Trials

7 trials available for prazosin and Pelvic Pain

ArticleYear
[Triple acupuncture at the Qugu acupoint as an adjunctive therapy for type-Ⅲ chronic prostatitis: Analysis of short- and long-term clinical effects].
    Zhonghua nan ke xue = National journal of andrology, 2017, Volume: 23, Issue:5

    Topics: Acupuncture Points; Acupuncture Therapy; Anti-Bacterial Agents; Chronic Disease; Chronic Pain; Combi

2017
A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome.
    International urology and nephrology, 2016, Volume: 48, Issue:1

    Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Chronic Disease; Drug Therapy, Combination; Huma

2016
[Retrospective analysis of the combined therapy of terazosin with chlormezanone for chronic prostatitis/chronic pelvic pain syndrome].
    Zhonghua nan ke xue = National journal of andrology, 2009, Volume: 15, Issue:8

    Topics: Adult; Chlormezanone; Chronic Disease; Drug Therapy, Combination; Humans; Male; Middle Aged; Pain Me

2009
[Dexketoprofen trometamol in the treatment of chronic prostatitis/chronic pelvic pain syndrome].
    Zhonghua nan ke xue = National journal of andrology, 2009, Volume: 15, Issue:9

    Topics: Adult; Chronic Disease; Humans; Indomethacin; Ketoprofen; Male; Pelvic Pain; Prazosin; Prostatitis;

2009
Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
    The Journal of urology, 2003, Volume: 169, Issue:2

    Topics: Adrenergic alpha-Antagonists; Adult; Chronic Disease; Humans; Male; Middle Aged; Pelvic Pain; Prazos

2003
Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.
    Urology, 2004, Volume: 64, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adult; Chronic Disease; Double-Blind Method; Follow-Up Studies; Humans

2004
More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study.
    Prostate cancer and prostatic diseases, 2006, Volume: 9, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adult; Combined Modality Therapy; Humans; Magnetics; Male; Middle Aged

2006

Other Studies

3 other studies available for prazosin and Pelvic Pain

ArticleYear
Issues in designing a randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome: Comment on Wang et al. Randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/
    International urology and nephrology, 2017, Volume: 49, Issue:3

    Topics: Humans; Levofloxacin; Male; Pelvic Pain; Prazosin; Prostatitis

2017
Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.
    Urology, 2005, Volume: 66, Issue:1

    Topics: Chronic Disease; Humans; Male; Pelvic Pain; Prazosin; Prostatitis; Syndrome; Time Factors

2005
Prostatodynia in United Nations peacekeeping forces in Haiti.
    Military medicine, 1997, Volume: 162, Issue:6

    Topics: Abscess; Adrenergic alpha-Antagonists; Adult; Age Factors; Anti-Bacterial Agents; Chronic Disease; C

1997